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Abstract
Integration of laboratory training into the Centers for Disease Control and Prevention’s (CDC) 
Field Epidemiology Training Program (FETP) began in 2004 and has advanced the training of 
laboratory scientists worldwide on the basic principles of epidemiology, disease surveillance, and 
outbreak investigation. The laboratory component of the FE(L)TP training has traditionally been 
disease specific, revolving around classroom and bench training on laboratory methods, and field 
placement in areas where services are needed. There is however a need to improve the integration 
of epidemiology elements used in surveillance, outbreak investigation, and evaluation activities 
with specific measurable laboratory activities that could in turn impact the overall disease 
surveillance and response. A systematic and clear evaluation guideline for the laboratory 
components of disease surveillance systems alongside the corresponding epidemiological 
indicators can better identify, address, and mitigate weaknesses that may exist in the entire 
surveillance system, and also help to integrate and standardize the FE(L)TP curriculum content. 
The institution of laboratory Quality Management System principles linked to a comprehensive 
surveillance evaluation scheme will result in improved disease surveillance, response, and overall 
laboratory capacity over time.
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Introduction
The Field Epidemiology Training Program (FETP) is modeled on the Center for Disease 
Control and Prevention’s (CDC) Epidemic Intelligence Service (EIS) program and it 
combines classroom teaching with field experience in training epidemiologists on disease 
surveillance and response.1 Worldwide, over 50 such programs exist.2 The introduction of 
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers 
for Disease Control and Prevention or the Agency for Toxic Substances and Disease Registry.
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the ‘L’ or laboratory training as a component of the FETP is relatively new and was first 
introduced into an established FETP in Africa in 2004 in response to poor laboratory 
systems and structures in these settings.3 Most FETPs at present are academic in nature, are 
administered by the respective Ministry of Health (MOH) and academic institutions in each 
country, and award a Master’s degree to graduates. Examples include the Kenya, South 
Africa, Tanzania, and Nigeria FE(L)TPs. The general aim of the laboratory component is to 
bridge the gap that often exists between the epidemiology part of disease surveillance and 
outbreak investigation and the corresponding laboratory components of these activities. 
Linkage between these essential parts would result in improved surveillance and outbreak 
response, better programmatic outcomes, and strengthened networks and health systems. 
The curriculum design in these programs is generally based on competencies, deliverables, 
learning activities, and field placement.
A key competency requirement for the students (residents) of any FETP is the evaluation of 
a national disease surveillance system. A national disease surveillance system is described as 
the sum of all surveillance activities to monitor diseases with high burden, to detect 
outbreaks of epidemic-prone diseases, and to monitor progress toward eradication targets.4 
The evaluation of a disease surveillance system generally follows the model proposed by the 
CDC standard guidelines and updates5,6 and provides the basis for system description, 
system assessment, and system improvement. These guidelines are a roadmap to specific 
measures and observations used to characterize any disease surveillance system.
Over the years, many surveillance systems have been evaluated throughout the world as part 
of the FETPs or as the target of other monitoring and evaluation activities. The CDC 
guidelines describe several attributes or characteristics of the system by which to gauge the 
system performance. These attributes fall into broad categories such as system flexibility, 
acceptability, simplicity, representativeness, timeliness, stability, and sensitivity among 
others. By gathering objective evidence by which to rate and evaluate these attributes for 
each disease system, one can conclude whether the surveillance system is effective or not or 
which elements are weak and need further support. Many laboratory functions can also fall 
into these attribute categories and do in fact have a direct effect on some system attributes, 
such as timeliness. But only limited descriptions exist for many of these laboratory elements 
that have potential impact on all the system attributes. A comprehensive list of these 
elements can significantly assist the system evaluation as described in the CDC guidelines 
by either laboratory personnel or by those without a laboratory background. Improved 
identification and appropriate linkages with important laboratory contributors to a disease 
surveillance system would have desired outcomes. First, the evaluation of disease 
surveillance systems, with the aid of a clear list of laboratory indicators, can be used by 
FE(L)TP epidemiologists and laboratory scientists alike for a more thorough assessment of 
national surveillance systems. Such an evaluation can be similarly used in clinical 
laboratories that may also be involved in disease surveillance or are part of a national 
laboratory surveillance and response network. This can in turn lead to more targeted 
interventions and effective, sustainable improvements in the surveillance system over time. 
Second, the creation of a clear guideline addressing the appropriate laboratory measures in 
national surveillance systems can be used as a model for better integration and 
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standardization of the joint laboratory and epidemiology components in the FE(L)TP 
curriculum, activities, and projects.
The relative novelty of incorporation of the laboratory component into the FETPs has 
contributed to lack of a standard laboratory curriculum model from one FE(L)TP to next. 
The incorporation of a clear guideline for laboratory indicators and measures in support of 
the surveillance system evaluation activities and inclusion of laboratory assessment in the 
FE(L)TP curriculum can help bridge the gaps in these programs. Validated tools for 
laboratory assessment are readily available and can be adopted for this purpose. Examples of 
commonly used mechanisms for independent stand-alone laboratory evaluation and 
assessment include the ISO (International Standards Institute) and CLSI (Clinical 
Laboratory Standards Institute-formerly NCCLS) developed guidelines and 
questionnaires,7–9 WHO’s laboratory questionnaire,10 and other measures for programmatic 
activities such as HIV/AIDS.11 Laboratory system assessment is often based on the 12 
Quality System Essentials (QSEs) that make up the larger laboratory Quality Management 
System (QMS).8 Laboratory QMS is the sum of all activities that must be in place to insure 
quality in all laboratory functions. The QSEs address all pre-analytic, analytic, and post-
analytic activities related to testing of samples in the laboratory.8 We propose a set of clear 
laboratory indicators that can be used to better integrate the components of and improve the 
national disease surveillance system evaluation. These indicators can be used to develop 
standard laboratory curricula and laboratory systems-related projects for the FE(L)TPs and 
set the course for targeted national laboratory capacity-building activities.
Disease Surveillance System Evaluation
The standard disease surveillance system evaluation used by FETPs is based on CDC 
recommendations for monitoring the public health response system. This document was 
published in 1988 as Guidelines for Evaluating Surveillance Systems5 and updated in 2001 
in the Morbidity and Mortality Weekly Report Recommendations as Updated Guidelines for 
Evaluating Public Health Surveillance Systems.6 Under these guidelines, evaluation 
activities are divided into several major tasks that help in describing the system and its 
importance, focus the evaluation design and purpose, identify stakeholders, gather credible 
evidence of system performance, and finally describe and measure the most important 
attributes linked to performance.
Important surveillance attributes that are assessed include measures of each system’s 
simplicity, flexibility, data quality, acceptability, sensitivity, predictive value positive, 
representativeness, timeliness, and stability. These variables individually and in sum 
determine the quality or effectiveness of the system being evaluated. Most disease 
surveillance systems, including both chronic and infectious diseases, have laboratory 
components and activities that generate supportive and confirmatory evidence of disease. 
Some surveillance systems may be more laboratory based. These include serologic 
surveillance and monitoring of targeted animal populations for enzootic diseases or 
epizootic events, and also survey activities that depend on examination of disease markers or 
indicators such as specific antibodies to infectious agents in sentinel populations.
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The surveillance evaluation guidelines are ultimately intended as tools to help generate 
improved data for measuring the true burden of disease; to monitor disease trends; to plan 
and implement evidence-based policies, programs, and practices; to allocate appropriate 
resources; and to set the stage for epidemiological research. Only a few attributes of the 
surveillance evaluation scheme, however, clearly address supporting laboratory variables and 
indicators. We propose the elaboration of specific and well-defined laboratory metrics to 
match and link to the other components of the surveillance system to bridge the gap more 
effectively between the two types of variables and measures – one epidemiologic or program 
based and the other laboratory based.
Laboratory Indicators in Surveillance System Evaluation
Although the various attributes used in the surveillance system evaluation address strengths 
and weaknesses in terms of the program targets and health policies and activities, 
corresponding laboratory indicators also need to be evaluated as an integral part of the 
surveillance system. Table 1 shows a summary of surveillance system attributes and the 
likely corresponding laboratory measures. This list can be used by epidemiologists and 
laboratory scientists in carrying out disease surveillance system evaluations.
An objective evaluation of the laboratory functions and indicators of quality as part of the 
larger surveillance system measures can point out the system strengths and weaknesses on a 
more comprehensive basis. Evaluation of laboratory measures and indicators as they relate 
to disease surveillance and investigation can form the basis for recommending measures and 
activities to improve the quality of laboratory results. Clinical labs that adopt and use many 
of the key items in the proposed scheme may also benefit from the information gathered in 
such an evaluation. Linked laboratory indicators can be used to monitor performance and 
laboratory contributions to targeted surveillance systems.
Lastly, laboratory focused activities, such as quality improvement projects, can be 
incorporated into the laboratory curriculum as deliverables or as outcomes for the laboratory 
scientists in the FE(L)TPs or in any pre- and in-service laboratory training program, such as 
those for clinical laboratory scientists. These activities can also be used independently to 
complement laboratory assessments and capacity-building activities that use the laboratory 
QMS framework.
Targeted Activities to Improve Laboratory Results and Surveillance System 
Quality
Through several approaches, FE(L)TPs can improve the quality of laboratory functions, 
including testing and capacity development. Laboratory bench training is part of the 
curriculum used by some FE(L)TPs to improve laboratory residents’ level of technical skills 
and knowledge. Training on new diagnostic tools and methods to respond to priority 
diseases is necessary to build capacity, however training activities are generally technology 
driven and disease focused. They may not always address the wider (systems) issues in 
laboratory quality. The addition of laboratory QMS training to the curriculum addresses the 
overall quality system components that directly or indirectly impact disease surveillance.
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Quality system variables include many indicators, from staff training and competence in 
performing laboratory assays, to sample collection, transport, and quality control and 
assurance, to documentation and reporting or dissemination of results (Table 1). Many 
fundamental activities are deemed critical to obtaining reliable, valid, laboratory results and 
timely reporting. These include proper sample collection, transport, and results 
documentation and dissemination. They fall in the pre- and post-analytic phases of sample 
management and quality assurance, as well as in the analytic phase (Figure 1).
QSEs address the requirements for quality results and products in all phases of the quality 
assurance cycle. They cover the following 12 areas: personnel, organization, documents and 
records, process control, assessment and audit, equipment, purchasing and inventory, 
information management, occurrence management, process improvement, facilities and 
safety, and customer service and satisfaction (Figure 2). With proper guidance and 
mentorship, laboratory residents in the FE(L)TPs can use the appropriate QSEs as tools for 
targeting key laboratory indicators for disease surveillance system improvements. These 
activities can be part of the ongoing projects and competencies of the FE(L)TPs or any other 
laboratory training program, and will contribute to the development of national laboratory 
systems and capacities.
Conclusion
We propose the evaluation of disease surveillance systems as an entry point for integration 
of epidemiology and laboratory components in the standard FE(L)TP curriculum. 
Surveillance system evaluation provides a natural framework for this synthesis, as it is a 
fundamental activity in the FE(L)TP curriculum and validated guidelines are available. 
Other unexplored opportunities and possibilities may exist for laboratory integration into 
FETP curriculum and activities. These include the presence of clear definitions, strategies, 
and organization of the joint laboratory and epidemiology processes during disease outbreak 
investigations, plus additional improvements in designing planned epidemiologic studies, 
especially those with substantial laboratory contributions. These activities naturally require 
effective collaboration between laboratory scientists and epidemiologists, and they help 
build capacities that strengthen the overall surveillance system.
The weaknesses found in laboratory-related surveillance activities can be addressed as part 
of recommendations through FE(L)TP reports and findings or separately as part of national/
sub-national laboratory assessments and audits performed internally by institutions or by 
independent assessment bodies. Recommendations from either effort will require 
appropriate laboratory QMS intervention measures, including training, continuous 
monitoring, and evaluation. The capacity for and feasibility of performing laboratory 
assessment to obtain key objective information on quality measures and surveillance 
capabilities is commonly dependent on several factors. These include national and local laws 
and regulations governing clinical, public health, and other laboratories; national laboratory 
(strategic) planning; a competent workforce that is sufficient in number; and finally support 
and guidance from key health and governmental authorities.
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FE(L)TPs serve an important function by creating cadres of well-trained epidemiologists 
and laboratory scientists who not only can conduct proper surveillance and disease 
investigation, but can also address the elements of good laboratory practice and laboratory 
quality management. Placement of laboratory residents from FE(L)T programs at central 
national reference levels and at sub-national laboratories would in the long term build a 
sustainable culture of quality as skills are passed on to other laboratory scientists during pre-
service and in-service training.
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Figure 1. 
The quality assurance cycle.
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Figure 2. 
Quality System Essentials in the laboratory Quality Management System.
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Table 1
Surveillance system evaluation attributes and corresponding laboratory indicators
Attributes Epidemiology/Surveillance program indicators Corresponding laboratory indicatorsa
Simplicity • Amount and type of data
• Number of organizations involved
• Level of integration of system
• Method of data collection
• Extent of data management, analysis, and 
dissemination
• Staff requirements
• Maintenance of the surveillance system
• Test complexity
• Test algorithm
• Level of lab training needed to perform 
test
• Specimen number required for diagnosis
• Specimen collection and transportation 
ease or difficulty
• Reporting of lab results ease or difficulty
• Dissemination of laboratory results ease 
or difficulty
Flexibility • Adaptability to changing needs, 
definitions, and conditions
• Test format or platform easily adaptable 
or changeable for given conditions
• Adaptability of tests and assays to 
environmental factors and conditions
• Adaptability of test to process 
improvement
Data quality • Validity of data
• Completeness of data
• Sensitivity and predictive value positive of 
the system based on data
• Specimen quality, such as appropriate 
sample, and quantity
• Transport conditions such as time in 
transport and temperatures
• Test and assay characteristics such as 
sensitivity, specificity, Predictive Value 
of Positive (PVP), Predictive Value of 
Negative (PVN), testing reliability, and 
validity
• Robustness of the testing algorithm
• Quality, condition, and control of lab 
equipment and instrumentation and their 
upkeep
• Presence and routine use of quality 
control samples, quality assurance, 
external quality assessment (EQA) 
Programs, and elements of lab Quality 
Management System (QMS)
• Accurate laboratory documentation, 
reporting, and record keeping
• Clearly understandable content, design, 
and accuracy of laboratory reports
• Adequate staff training
• Evidence of staff competence through 
EQA participation
Acceptability • Willingness of stakeholders to participate 
in the surveillance system
• Interview and report completion
• Reporting rate
• Timeliness of data reporting
• Laboratory’s role and importance in 
disease surveillance and reporting
• Quality of the lab assays
• Complexity of the lab assays
• Cost of laboratory testing
• Frequency of lab testing and reporting
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Attributes Epidemiology/Surveillance program indicators Corresponding laboratory indicatorsa
• Confidentiality and privacy of test results 
observed
• Responsiveness of lab to process 
improvement in testing and reporting 
frequencies
Sensitivity • Occurrence of disease
• Existence of case definitions
• Existence of active surveillance
• Quality of diagnosis and reporting of cases 
and those that are ruled out
• Quality of data on health status
• Laboratory tests exist for the disease or 
condition
• Tests are utilized properly
• Assay sensitivity and specificity for 
screening and confirmatory tests are 
relatively high (>95%)
• Ongoing laboratory testing is an integral 
part of the national surveillance and 
reporting system
• Advanced assays exist especially for 
linking cases and finding common 
sources (molecular epidemiology)
Predictive value positive • Confirmation of cases reported by system
• Detection of true outbreaks/epidemics
• Knowledge of baseline disease prevalence
• Sensitivity and specificity of case 
definition
• Existence of complete medical records, 
registries, death certificates, outbreak 
investigation records, communication of 
information
• Sensitivity and specificity of the 
screening and confirmatory tests
• Prevalence of disease in the population
• PVP for lab tests used
• Complete lab records and documentation 
for test results
• Percentage of samples that due to various 
reasons cannot be lab-confirmed and test 
negative for the disease of interest
Representativeness • Characteristics of the population and 
demographics
• Characteristics of the disease and its 
clinical course
• Nature of medical and diagnostic practices
• Existence of multiple data sources for 
comparison with reported incidence
• Number of laboratories performing 
diagnostic testing for the given disease or 
condition
• Location of laboratories in given regions
• Extent of laboratory services provided 
for given populations
• Type and quality (sensitivity, specificity, 
PVP, PVN) of tests used in each location 
for the disease or condition
• Lab QMS practices in regional and 
central laboratories
Timeliness • Time interval between stages in diagnosis, 
reporting, and control/prevention for the 
given disease or condition
• Disease characteristics and latency
• ability to access data quickly
• Time requirements for specimen 
collection, transport, and testing
• Turn-around time for laboratory results 
to physician or health agency
• Existence of valid, reliable rapid tests for 
disease or condition
• Existence of electronic laboratory-based 
surveillance system and rapid 
dissemination of data
aCorrespondence may not necessarily be one to one between epidemiology and laboratory bulleted items.
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